Becton Dickinson was founded in 1897 by two American businessmen; Maxwell W. Becton and Fairleigh S. Dickinson. The duo met on a sales trip, and right from the commencement; the company experienced dramatic growth. It has set its base in New Jersey, the U.S, with worldwide operations.
BD created and sold its first product the same year it was formed; a Luer-all-glass syringe. This opened the company’s doors to discovery, manufacturing, and provision of innovative solutions within the medical device industry.
As a global medical technology company, BD supports advanced clinical processes. It ensures the delivery of quality care of technologies, which enhance medical research and clinical laboratories. It has put more power and investment in the diagnosis of infectious disease and cancer, intervention procedures, and management of diabetes.
The company operates in more than 50 countries across the world. It serves the pharmaceutical industry, health care institutions, clinical laboratories, and science researchers. It is also has a listing on the NYSE market.
Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.